Combined Bilateral Salpingo-oophorectomy and Cesarean Delivery in BRCA1/2 Alteration Carriers: A Case Series

被引:1
|
作者
Barker, Victoria E. [1 ,2 ]
Vlachodimitropoulou, Evangelia [1 ,2 ]
O'Brien, Patrick [1 ,2 ]
Iskaros, Joseph [1 ,2 ]
Rosenthal, Adam N. [1 ,2 ,3 ]
机构
[1] Univ Coll London Hosp, Natl Hlth Serv Fdn Trust, London, England
[2] UCL, Univ Coll London Elizabeth Garrett Anderson Inst W, Dept Womens Canc, London, England
[3] Univ Coll London Hosp NHS Fdn Trust, London, England
关键词
BREAST-CANCER; OVARIAN; RISK; WOMEN;
D O I
10.1097/AOG.0000000000005423
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The cumulative lifetime risk of ovarian cancer is 16-68% and 11-30% in female BRCA1 and BRCA2 gene alteration carriers, respectively. Risk-reducing bilateral salpingo-oophorectomy (RRSO) is the only proven way to reduce ovarian cancer mortality. We report a series of patients who underwent risk-reducing surgery at the time of planned obstetric-indicated cesarean delivery.CASES: This is a case series of four women carrying a pathogenic germline BRCA1 or BRCA2 gene alteration who underwent RRSO at the time of cesarean delivery between March 1, 2018, and March 31, 2022. All women were referred during pregnancy to the University College London Hospitals Familial Cancer Clinic for consideration of RRSO at the time of obstetric-indicated cesarean delivery. Women were considered eligible for RRSO if they had a proven pathogenic germline alteration, would have completed childbearing after the cesarean delivery, and were older than age 35 or 40 years with BRCA1 or BRCA2 alterations, respectively. Operating time, blood loss, transfusion requirements, length of hospital stay, complications, and ability to breastfeed were assessed and, where possible, compared with the institutional means for similar patients who underwent cesarean delivery only, to determine whether RRSO was associated with increased morbidity. Women were contacted 11-59 months postprocedure to assess satisfaction. The mean blood loss was 687 mL (range 400-1,000 mL), mean operating time was 68 minutes, mean length of hospital stay was 3 days, and mean change in hemoglobin was -1 g/dL. No patient required a transfusion, had internal organ damage, returned to the operating room, or was readmitted. One of two women with intact breast tissue successfully breastfed, and the other chose to bottle feed. The mean contemporaneous institutional blood loss for cesarean delivery was not significantly different at 681 mL for singleton pregnancies and 872 mL for twin pregnancies. All four women reported a high level of satisfaction with the combined procedure.CONCLUSION: Our results show that RRSO can be performed at the time of cesarean delivery with high patient satisfaction. This approach can be offered to appropriately counseled individuals, with the benefit of avoiding the need for two separate procedures, with potentially reduced patient morbidity and health care costs.
引用
收藏
页码:1500 / 1503
页数:4
相关论文
共 50 条
  • [21] Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers
    Fakkert, Ingrid E.
    Mourits, Marian J. E.
    Jansen, Liesbeth
    van der Kolk, Dorina M.
    Meijer, Kees
    Oosterwijk, Jan C.
    van der Vegt, Bert
    Greuter, Marcel J. W.
    de Bock, Geertruida H.
    CANCER PREVENTION RESEARCH, 2012, 5 (11) : 1291 - 1297
  • [22] Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation
    Hall, Elizabeth
    Finch, Amy
    Jacobson, Michelle
    Rosen, Barry
    Metcalfe, Kelly
    Sun, Ping
    Narod, Steven A.
    Kotsopoulos, Joanne
    GYNECOLOGIC ONCOLOGY, 2019, 152 (01) : 145 - 150
  • [23] Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers
    Domchek, Susan M.
    Friebel, Tara M.
    Garber, Judy E.
    Isaacs, Claudine
    Matloff, Ellen
    Eeles, Rosalind
    Evans, D. Gareth
    Rubinstein, Wendy
    Singer, Christian F.
    Rubin, Stephen
    Lynch, Henry T.
    Daly, Mary B.
    Weitzel, Jeffrey
    Ganz, Patricia A.
    Pichert, Gabriella
    Olopade, Olufunmilayo I.
    Tomlinson, Gail
    Tung, Nadine
    Blum, Joanne L.
    Couch, Fergus
    Rebbeck, Timothy R.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (01) : 195 - 203
  • [24] Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation
    Jung, Sung Mi
    Ryu, Jai Min
    Park, Hyung Seok
    Park, Ji Soo
    Kang, Eunyoung
    Lee, Seeyoun
    Lee, Han-Byoel
    Youn, Hyun Jo
    Yoo, Tae-Kyung
    Kim, Jisun
    Lee, Jeong Eon
    Han, Sang Ah
    Kim, Dongwon
    Kim, Sung-Won
    JOURNAL OF BREAST CANCER, 2020, 23 (06) : 647 - 655
  • [25] Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy
    J. V. Cohen
    L. Chiel
    L. Boghossian
    M. Jones
    J. E. Stopfer
    J. Powers
    T. R. Rebbeck
    K. L. Nathanson
    S. M. Domchek
    Familial Cancer, 2012, 11 : 69 - 75
  • [26] The psychosexual effects of risk-reducing bilateral salpingo-oophorectomy in female BRCA1/2 mutation carriers: A systematic review of qualitative studies
    Hickey, India
    Jha, Swati
    Wyld, Lynda
    GYNECOLOGIC ONCOLOGY, 2021, 160 (03) : 763 - 770
  • [27] Salpingectomy With Delayed Oophorectomy Versus Salpingo-Oophorectomy in BRCA1/2 Carriers: Three-Year Outcomes of a Prospective Preference Trial
    Van Bommel, Majke H. D.
    Steenbeek, Miranda P.
    Inthout, Joanna
    Van Garderen, Tessa
    Harmsen, Marline G.
    Arts-De Jong, Marieke
    Maas, Angela H. E. M.
    Prins, Judith B.
    Bulten, Johan
    Van Doorn, Helena C.
    Mourits, Marian J. E.
    Tros, Rachel
    Zweemer, Ronald P.
    Gaarenstroom, Katja N.
    Slangen, Brigitte F. M.
    Brood-Van Zanten, Monique M. A.
    Vos, M. Caroline
    Piek, Jurgen M. J.
    van Lonkhuijzen, Luc R. C. W.
    Apperloo, Mirjam J. A.
    Coppus, Sjors F. P. J.
    Hoogerbrugge, Nicoline
    Hermens, Rosella P. M. G.
    De Hullu, Joanne A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2025, : 782 - 794
  • [28] Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers
    Kenkhuis, M. J. A.
    de Bock, G. H.
    Elferink, P. Oude
    Arts, H. J. G.
    Oosterwijk, J. C.
    Jansen, L.
    Mourits, M. J. E.
    MATURITAS, 2010, 66 (03) : 310 - 314
  • [29] The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study
    Rudaitis, Vilius
    Mikliusas, Vismantas
    Januska, Gediminas
    Jukna, Povilas
    Mickys, Ugnius
    Janavicius, Ramunas
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 247 : 26 - 31
  • [30] BRCA1/2mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study
    Lynce, Filipa
    Schlam, Ilana
    Geng, Xue
    Peshkin, Beth N.
    Friedman, Sue
    Dutil, Julie
    Nahleh, Zeina
    Campos, Claudia
    Ricker, Charite
    Rodriguez, Patricia
    Denduluri, Neelima
    Ahn, Jaeil
    Isaacs, Claudine
    Graves, Kristi D.
    JOURNAL OF GENETIC COUNSELING, 2021, 30 (02) : 383 - 393